These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35361787)

  • 1. SINBAD, structural, experimental and clinical characterization of STAT inhibitors and their potential applications.
    Plens-Gałąska M; Woźniak T; Wesoły J; Bluyssen HAR
    Sci Data; 2022 Mar; 9(1):139. PubMed ID: 35361787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating Signal Transducer and Activator of Transcription (STAT) Protein-Inhibitor Interactions Using Biochemical and Cellular Thermal Shift Assays.
    Attarha S; Reithmeier A; Busker S; Desroses M; Page BDG
    ACS Chem Biol; 2020 Jul; 15(7):1842-1851. PubMed ID: 32412740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation.
    Xia L; Wang L; Chung AS; Ivanov SS; Ling MY; Dragoi AM; Platt A; Gilmer TM; Fu XY; Chin YE
    J Biol Chem; 2002 Aug; 277(34):30716-23. PubMed ID: 12070153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells.
    Padros J; Chatel G; Caron M
    J Vis Exp; 2021 Sep; (175):. PubMed ID: 34570089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of STAT signaling by STAT-interacting proteins.
    Shuai K
    Oncogene; 2000 May; 19(21):2638-44. PubMed ID: 10851063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions.
    Mazzarella G; MacDonald TT; Salvati VM; Mulligan P; Pasquale L; Stefanile R; Lionetti P; Auricchio S; Pallone F; Troncone R; Monteleone G
    Am J Pathol; 2003 Jun; 162(6):1845-55. PubMed ID: 12759242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of heat stress on prolactin-mediated ovarian JAK-STAT signaling in postpubertal gilts.
    Roach CM; Bidne KL; Romoser MR; Ross JW; Baumgard LH; Keating AF
    J Anim Sci; 2022 Jul; 100(7):. PubMed ID: 35772766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing STATs: lessons from paramyxovirus interferon evasion.
    Horvath CM
    Cytokine Growth Factor Rev; 2004; 15(2-3):117-27. PubMed ID: 15110796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3.
    Minamoto S; Ikegame K; Ueno K; Narazaki M; Naka T; Yamamoto H; Matsumoto T; Saito H; Hosoe S; Kishimoto T
    Biochem Biophys Res Commun; 1997 Aug; 237(1):79-83. PubMed ID: 9266833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT nuclear translocation: potential for pharmacological intervention.
    Meyer T; Vinkemeier U
    Expert Opin Ther Targets; 2007 Oct; 11(10):1355-65. PubMed ID: 17907964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription.
    Catlett-Falcone R; Dalton WS; Jove R
    Curr Opin Oncol; 1999 Nov; 11(6):490-6. PubMed ID: 10550013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases.
    Godoi MA; Camilli AC; Gonzales KGA; Costa VB; Papathanasiou E; Leite FRM; Guimarães-Stabili MR
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
    Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
    Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs.
    Plens-Galaska M; Szelag M; Collado A; Marques P; Vallejo S; Ramos-González M; Wesoly J; Sanz MJ; Peiró C; Bluyssen HAR
    Front Immunol; 2018; 9():2141. PubMed ID: 30283459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology.
    Recio C; Guerra B; Guerra-Rodríguez M; Aranda-Tavío H; Martín-Rodríguez P; de Mirecki-Garrido M; Brito-Casillas Y; García-Castellano JM; Estévez-Braun A; Fernández-Pérez L
    Oncogene; 2019 Jun; 38(24):4657-4668. PubMed ID: 30783189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.
    Zhao R; Hu Z; Zhang X; Huang S; Yu G; Wu Z; Yu W; Lu J; Ruan B
    Cell Commun Signal; 2024 Jan; 22(1):68. PubMed ID: 38273295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.
    Xue C; Yao Q; Gu X; Shi Q; Yuan X; Chu Q; Bao Z; Lu J; Li L
    Signal Transduct Target Ther; 2023 May; 8(1):204. PubMed ID: 37208335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STATs signaling pathways in dendritic cells: As potential therapeutic targets?
    Sohrabi S; Masoumi J; Naseri B; Ghorbaninezhad F; Alipour S; Kazemi T; Ahmadian Heris J; Aghebati Maleki L; Basirjafar P; Zandvakili R; Doustvandi MA; Baradaran B
    Int Rev Immunol; 2024 May; 43(3):138-159. PubMed ID: 37886903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer.
    Singh N; Hussain S; Bharadwaj M; Kakkar N; Singh SK; Sobti RC
    J Recept Signal Transduct Res; 2012 Dec; 32(6):321-7. PubMed ID: 23134344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.